「was」の検索結果
27件：16～20件目を表示
-
the orphan drug designation to the in-house developed compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as an orphan drug ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
1回1滴で、充血クリアｌマイティアルミファイｌ千寿製薬
2 投与1４日目の結膜充血スコアの推移 （平均値 ± 標準誤差）（Full Analysis Set） ※Use of the ORA Calibra Redness/Hyperemia Scale was made under license from Ora,Inc 安全性 ＋ ー 安全性評価において、副作用として本品群109人中1人（0.9%）に軽度の眼圧低下が認められましたが、発現後も本品...
https://www.senju.co.jp/consumer/mytearlumify -
NewMytear A | OTC Products, etc. | Products | SENJU Pharmaceutical
yes. This medicine is an eye drop close to tears. The ion balance of sodium, potassium, and calcium was made closer to normal tears. This medicine contains calcium that is important for maintaining th...
http://www.senju.co.jp/english/products/myteara.html -
the orphan drug designation to the in-house developed compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as an orphan drug ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
cated for improvement of symptoms of Dry Eye Disease due to MGD (Meibomian Gland Dysfunction ), and was previously approved by the Ministry of Health, Labor and Welfare in Japan. It has a preset treat...
https://www.senju.co.jp/system/files/content_news/2023-11/ENG__20231101_0.pdf